JDRF names Jeffrey Brewer president, CEO
NEW YORK The Juvenile Diabetes Research Foundation has appointed a new president and CEO.
Entrepreneur and philanthropist Jeffrey Brewer -- who has been a JDRF volunteer since 2002 -- was named the organization's new leader. Brewer, as served as a director of JDRF’s international board since 2004, is a reviewer on JDRF’s Lay Review Committee (which judges the potential of diabetes research from the perspective of people impacted by diabetes), and has been an active member and donor for the foundation’s New York Chapter.
Prior to becoming the new leader of JDRF, Brewer was co-founder of Overture Services, formerly known as GoTo.com, in 1998; he also served as CEO and a director. GoTo.com was the first pay-for-placement and pay-for-click search advertising system.
“Jeffrey Brewer has all the qualities we were looking for in a leader for JDRF: experience in managing large and growing organizations, a detailed understanding of diabetes research, and a track record of success,” said Frank Ingrassia, chairman of the JDRF board of directors. “When you add to that a drive and passion for finding a cure, based on his own family experience with diabetes and the people around the world he has met in his years as a volunteer with JDRF, that’s a terrific combination to help us speed progress towards the cure.”
Added Brewer, “As a volunteer, it is so humbling and rewarding to work side by side with our passionate volunteers and our impressive staff in our collective effort to advance the pace of research leading to better treatments and cures for people with diabetes. I feel we are on the cusp of exciting research progress that can make a real difference in the lives of people living with this terrible disease – including some tangible advances delivered to patients in the not-too-distant future. I'm honored to become a full-time part of driving us towards our goals, and helping us translate research into drugs and devices that will help people with Type 1 diabetes live better, longer and healthier, and ultimately to remove this disease from people's lives forever.”